Bausch Health Companies Inc $ 19.24 0.11 (0.58%)
On watch
Volume:
1,104,840
Avg Vol (1m):
3,929,652
Market Cap $:
6.51 Bil
Enterprise Value $:
31.11 Bil
P/E (TTM):
0.00
P/B:
8.69
Financial Strength | 2/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Cash-To-Debt | 0.04 | ||
| Equity-to-Asset | 0.02 | ||
| Debt-to-Equity | 33.98 | ||
| Debt-to-EBITDA | 14.49 | ||
| Interest Coverage | 0.81 | ||
| Piotroski F-Score | 5 | ||
| Altman Z-Score | 0.04 | ||
| Beneish M-Score | -2.75 | ||
| WACC vs ROIC | |||
Profitability Rank | 4/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Operating Margin % | 15.18 | ||
| Net Margin % | -21.7 | ||
| ROE % | -98.09 | ||
| ROA % | -5.75 | ||
| ROC (Joel Greenblatt) % | -19.17 | ||
| 3-Year Revenue Growth Rate | -4.7 | ||
| 3-Year EBITDA Growth Rate | -7.4 | ||
| 3-Year EPS without NRI Growth Rate | 10.3 |
Valuation Rank | 10/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Forward PE Ratio | 4.47 | ||
| PB Ratio | 8.66 | ||
| PS Ratio | 0.75 | ||
| Price-to-Free-Cash-Flow | 6.18 | ||
| Price-to-Operating-Cash-Flow | 4.78 | ||
| EV-to-EBIT | -115.4 | ||
| EV-to-EBITDA | 17.69 | ||
| EV-to-Revenue | 3.61 | ||
| Current Ratio | 1.13 | ||
| Quick Ratio | 0.9 | ||
| Days Inventory | 169.33 | ||
| Days Sales Outstanding | 75.71 | ||
| Days Payable | 72.43 |
Dividend & Buy Back |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -0.5 |
Valuation & Return |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Price-to-Intrinsic-Value-Projected-FCF | 0.42 | ||
| Price-to-Median-PS-Value | 0.17 | ||
| Earnings Yield (Greenblatt) % | -0.87 | ||
| Forward Rate of Return (Yacktman) % | 1.59 |